The FTSE 100 index had a weak start, posting its poorest opening in three weeks, as industrial miners and lenders dragged it down.
Share Talk Expected Market Updates For The Week Ahead, 24 – 28th April 2023
This week is filled with busy results announcements for London-listed companies, with big names like Barclays and NatWest, AstraZeneca and GSK, Unilever and Reckitt Benckiser, as well as US tech
FTSE 100 reaches new record high as Centrica shares jump
The FTSE 100 achieved a new record high with the help of positive corporate earnings from Centrica and Standard Chartered, while higher commodity prices buoyed miners.
FTSE 100 closes at record high (again)
The FTSE 100 has ended the trading day on another record high, closing 1.42pc higher at 7,947.60 points.
The FTSE 100 hits record high for third time in a week
The FTSE 100 reached an all-time record, buoyed in part by a string of positive earnings and merger talks linked to Standard Chartered.
Share Talk Expected Market Updates For The Week Ahead, 6th – 10th February 2023
The record-breaking closing high of the FTSE 100 has been broken by more big names in London’s index. They will be reporting results for the week ahead that could push
St Brides Partners Weekly Brief, Saturday 9th October 2021
As nightfall creeps up ever earlier on us and we begin to wake up in the dark, searching for the comfort of our warmest and cosiest clothing before leaving the
DeepMatter CEO Mark Warne Is Appointed Chairman of Industrial Advisory Board at Imperial College
DeepMatter Group Plc (AIM: DMTR, “DeepMatter”, the “Group”), which focuses on digitalising chemistry, announces that its CEO, Mark Warne, has been invited to chair the Industrial Advisory Board (IAB) at
AstraZeneca’s Chronic kidney disease Drug Forxiga approved by European Commission
AstraZeneca’s Forxiga (dapagliflozin), has been approved by the European Commission (EC). It is now available for chronic kidney disease (CKD), in adults with or without type-2 diabetes (T2D), in the
DeepMatter Group PLC (DMTR.L) Collaboration with the University of Cambridge
DeepMatter collaborates with the University of Cambridge’s Innovation Centre in Digital Molecular Technologies
£400m Life Sciences hub in Stevenage To Be Built By GSK creating up to 5000 jobs
GSK, the pharmaceutical giant, plans to open a PS400m science hub at Stevenage. This could lead to up to 5,000 new jobs. Work is expected to start in 2022.